ArticleScientific reports2025
Association between RBC folate and odds of osteoarthritis in adults aged 40-60 years.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Although the association between red blood cell (RBC) folate and osteoarthritis (OA) is still controversial, relevant evidence is continuously emerging. This study aimed to examine the relationship between RBC folate levels and the incidence of OA in adults aged 40-60. This cross-sectional analysis involved 7708 adults from the National Health and Nutrition Examination Survey 2009-2018. The independent variable was RBC folate, which reflects long-term folate status, and the outcome variable was the odds of OA. A logistic regression model was used to evaluate the association between RBC folate levels and the incidence of OA. Additionally, subgroup analyses were conducted by race, gender, and body mass index. After adjusting for other potential confounding factors, there was a positive association between RBC folate and the incidence of OA (OR 1.0024, 95% CI 1.0012-1.0036, P < 0.0001). When RBC folate was divided into four equal groups, in the fully adjusted model, participants in the highest quartile had a significant higher odds of OA than those in the lowest quartile (OR 1.3157, 95% CI 1.0532-1.6436, P = 0.0191). In adults aged 40 to 60 years, there was a J-shaped relationship between RBC folate and the incidence of OA (turning point: 102 nmol/dL, OR 1.0403, 95% CI 1.0242-1.0566, p < 0.0001). This indicates that when the RBC folate level exceeds 102 nmol/dL, for every 10 nmol/dL increase, the odds of OA rises by 4.03%. Our findings showed a positive association between RBC folate and the incidence of OA in adults aged 40-60. Further studies are required to explore its underlying mechanism and confirm this correlation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.